Thailand Aesthetic Devices Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Facial Injectable, Medical Laser-Based Devices, Ultrasound, Light-Based Devices, Microneedling Devices), By End Use (B2B, B2C), And Segment Forecasts

Thailand Aesthetic Devices Market Summary

The Thailand aesthetic devices market size was estimated at USD 224.43 million in 2025 and is projected to reach USD 582.27 million by 2033, growing at a CAGR of 12.6% from 2026 to 2033. The market's growth is attributed to increasing medical tourism in Thailand, growing preferences among youth for aesthetic procedures, technological advancements in aesthetic devices, and the increasing demand for non-surgical procedures.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Thailand has become one of the leading global destinations for medical tourism in aesthetic procedures, attracting patients with its combination of internationally accredited hospitals, skilled specialists, and competitive pricing.

The country offers a wide range of cosmetic treatments, from minimally invasive procedures to advanced surgeries, often at a fraction of the cost compared to Western nations. Thailand’s reputation for high-quality care and hospitality positions the country as a preferred choice for international clients seeking medical and aesthetic enhancements.

Aesthetic devices are medical technologies and equipment used for cosmetic treatments, such as skin rejuvenation, body contouring, and anti-aging procedures. These devices play a major role in modern aesthetic medicine, enabling safe, effective, and minimally invasive treatments that cater to the rising global demand for beauty and wellness solutions. Aesthetic procedures in Thailand have witnessed remarkable growth in recent years, supported by both domestic demand and international medical tourism.

“A rising trend in self-care, particularly among the younger generation. This trend, which includes skincare, nutritional supplements, and fitness, has contributed to a significant rise in aesthetic procedures”.

-          President of the Association of Plastic and Cosmetic Surgeons of Thailand

According to The Nation Thailand, a survey by the Economic Intelligence Center (EIC) shows that this demand continues to grow. This survey further revealed that 44% of respondents had undergone cosmetic procedures, while an additional 24% expressed interest despite no prior experience. Moreover, 63% of those who had undergone treatments received multiple procedures, reflecting a growing inclination toward comprehensive aesthetic enhancement.

Furthermore, the market is also witnessing a shift toward the increasing demand for non-surgical aesthetic procedures, reflecting changing patient preferences for less invasive treatments, involving shorter recovery periods, and carrying fewer risks than traditional surgery. According to the International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey 2024, 197,505 aesthetic procedures were performed in Thailand in 2024, of which 50,920 (around 26%) were non-surgical. The most common procedures in this category were botulinum toxin injections (29,925; 58.8%), hyaluronic acid fillers (10,450; 20.5%), non-surgical skin tightening (3,278; 6.4%), laser hair removal (2,708; 5.3%), and non-surgical fat reduction (2,375; 4.7%).

Similarly, advancements in aesthetic medical devices and injectables, and the country’s expertise in medical professionals are important factors driving the market's growth due to enhanced treatment safety, efficacy, and overall patient satisfaction.

Many Thai surgeons and physicians are internationally trained, often with qualifications and fellowships from leading United States, European, and Japanese institutions. This global exposure equips them with advanced knowledge and techniques, enabling them to deliver outcomes that meet international safety and quality standards. Thai doctors are also recognized for their precision, cultural sensitivity, and ability to integrate modern innovations with patient-centered care. According to Konkai Health, as of 2025, several of Thailand’s cosmetic surgeons are ranked among the top specialists in the region, further solidifying the country’s credibility in the global aesthetic landscape. The combination of medical expertise, international accreditation, and continuous professional development has positioned Thailand as a trusted destination for patients seeking surgical and non-surgical aesthetic procedures.

The table above lists Thailand's top 10 cosmetic surgeons, ranked according to their professional standing. These rankings underscore the strong individual reputation of Thai surgeons, which collectively enhances the country’s global appeal in aesthetic medicine.

Thailand’s booming beauty culture is evident in regional tourism initiatives spotlighting aesthetic wellness. In March 2025, the Tourism Authority of Thailand launched the Amazing Thailand Health & Beauty campaign in Cambodia in partnership with Visa. This initiative offered ASEAN travelers promotions on aesthetic services, raising awareness and encouraging broader aesthetic device adoption as part of wellness travel. This event aligns with the growing trend of medical tourism tied to rising aesthetic consciousness.

According to the International Trade Administration (ITA), Thailand is ranked 4^th in Asia after South Korea, Japan, and China in terms of revenue from medical aesthetic tourism. According to the International Society of Aesthetic Plastic Surgery, the most popular plastic surgery procedures in Thailand are:

Non-invasive procedures

• Facial shaping injections such as Botox and fillers

• Facelift, whitening, and pore-tightening laser

• Meso-lipolysis

Invasive procedures

• Nose and eye cosmetic surgery

• Breast surgery

• Liposuction

Thailand’s government has actively promoted aesthetic wellness alongside medical tourism to boost global demand for device-based cosmetic procedures. Medical tourism continues to be a powerhouse for Thailand’s cosmetic and aesthetics market. In 2023, Thailand served nearly 2.9 million medical tourists, generating approximately USD 850 million in medical tourism revenues, with around 25% seeking cosmetic treatments like fillers, liposuction, and laser therapies.

Market Concentration & Characteristics

The aesthetic devices industry in Thailand is largely fragmented. However, key hospital groups such as Bumrungrad International Hospital and Bangkok Hospital dominate the high-end segment by leveraging international medical tourism and advanced treatment facilities. At the same time, the market remains fragmented due to the large number of smaller clinics spread across Bangkok and other tourist hubs, which cater to domestic clients and price-sensitive international visitors. This dual structure-where a few large players command global visibility while numerous smaller providers ensure widespread accessibility defines the industry’s concentration and overall characteristics.

Thailand’s aesthetic device industry demonstrates a strong degree of innovation, driven by the introduction of advanced global technologies and their adaptation to local needs. For instance, Merz Aesthetics’ launch of regenerative biostimulators signals a shift toward natural, long-lasting treatments that leverage the body’s healing processes. Similarly, technologies showcased at IMCAS Asia 2025, such as Sylfirm X for treating darker skin with minimal downtime and Baz Biomedic’s Curejet needle-free injector, underline Thailand’s readiness to embrace multi-modality solutions tailored to regional demands.

To learn more about this report, Download Free Sample Report

Thailand’s aesthetic medical device industry is building strength through strategic alliances that enhance manufacturing and market reach. For instance, the joint venture between K.N.A. Inter Pharma and Diamond Biotechnology, investing over THB 2.5 billion in a new Pathum Thani plant, marks a milestone in domestic production and positions Thailand as a regional hub. On the commercial side, Merz Aesthetics’ B2B2C model, with partnerships across 500+ clinics, enables wide distribution of innovations like Ultherapy, German botulinum toxin, and Swiss fillers, reinforcing its leadership in the market.

Regulations in Thailand play a pivotal role in shaping the market for aesthetic devices by enforcing safety, quality, and ethical marketing standards. While not always covered by a dedicated framework, broader medical device laws build consumer trust and strengthen market credibility. For businesses, this oversight ensures fair competition and attracts international players, pushing local and global firms to prioritize certified, safe innovation, supporting sustainable, consumer-driven growth in the industry.

In Thailand’s aesthetic industry, substitutes include skincare products, injectables like Botox and fillers, surgical options such as facelifts, and wellness practices like spa therapies or herbal remedies. These alternatives appeal to consumers seeking lower-cost or familiar solutions, adding to competitive pressure. However, aesthetic devices offer safer, more precise, and longer-lasting results, strengthening their position as the preferred choice for clinics and patients.

Product Insights

The facial injectables segment accounted for the largest market share in 2025 and is projected to grow over the forecast period. Their popularity spans across age groups, driven by minimally invasive, cost-effective treatments that deliver natural results with little downtime. For instance, according to the ISAPS Global Survey 2024, Thailand reported 29,925 botulinum toxin procedures and 10,450 hyaluronic acid filler procedures, making up nearly 80% of all non-surgical treatments. This strong demand positions injectables as the cornerstone of Thailand’s aesthetic device market.

The medical laser-based devices segment is expected to grow significantly during the forecast period. These devices are valued for their versatility in treating skin resurfacing, pigmentation, scars, tattoos, and hair removal. They deliver minimally invasive, precise procedures with shorter recovery times, aligning with patient demand for convenient treatments. Technological advancements enhance safety and outcomes, while social media and the beauty industry accelerate awareness and adoption. These factors position lasers as a leading force in Thailand’s aesthetic medicine landscape.

End Use Insights

The B2B segment dominated the Thailand aesthetic device market in 2025, accounting for the largest revenue share. This growth is supported by the central role of hospitals, dermatology centers, and aesthetic clinics in administering device-based treatments through trained professionals and standardized protocols. These institutions ensure patient safety, regulatory compliance, and consistent treatment outcomes, strengthening trust and driving adoption. The recurring nature of aesthetic procedures, particularly injectables and energy-based treatments, further sustains demand within B2B channels by creating repeat business opportunities.

To learn more about this report, Download Free Sample Report

The B2C segment is expected to grow significantly during the forecast period. This growth is due to greater accessibility of aesthetic services and changing consumer lifestyle preferences. Thailand hosts nearly 7,000 aesthetic medicine clinics nationwide, including around 2,000 in Bangkok and 5,000 across other provinces, highlighting the growing penetration of consumer-facing services beyond traditional hospital-based settings. Rising cultural acceptance further supports this trend, particularly among younger generations; according to Siam Commercial Bank’s Economic Intelligence Center, 11% of Gen Z considered medical aesthetics highly important, outpacing older age groups. Combining widespread clinic availability with evolving consumer demand, these dynamics position the B2C channel for rapid expansion in Thailand’s aesthetic device market.

Key Thailand Aesthetic Devices Company Insights

The Thailand Aesthetic devices industry is highly competitive, with key players such as

AbbVie, Merz GmbH and Co. KGaA, and Galderma holding significant positions. The major companies undertake various organic and inorganic strategies such as product introduction, collaborations, and regional expansion to serve the unmet needs of their customers.

Recent Developments

• In June 2025, Wingderm participated in IMCAS Asia held in Bangkok, showcasing advanced medical aesthetic devices like Mesoskin, Lasermach, and Renuva. The event focused on Asia’s growing market and enabled Wingderm to align with trends, gain practitioner insights, and strengthen local partnerships for strategic expansion.

• In June 2025, Vimut Hospital launched a dedicated Facial Contouring Centre in Bangkok, expanding its cosmetic surgery offerings to meet rising demand for aesthetic treatments in Thailand.

• In March 2025, Alma Lasers, a Sisram Medical company, introduced Alma Harmony, a state-of-the-art aesthetic platform featuring advanced technology and five integrated laser and light systems. It enabled personalized, multi-wavelength treatments for diverse skin types and conditions. It offered enhanced energy, efficiency, and automated features for various aesthetic procedures, winning design awards globally.

• In January 2025, LG Chem announced the expansion of its aesthetic business in Thailand with the official launch of its PN Skin Booster “Vitaran,” marking a significant addition to regenerative injectables in the local market.

Thailand Aesthetic Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Thailand aesthetic devices market report based on product and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical Laser-Based Devices

  • Light-Based Devices

  • Radiofrequency (RF) Based Devices

  • Ultrasound

  • Facial Injectable

    • Skin Boosters

    • Hyaluronic Acid

    • Botulinum Toxin

    • Calcium Hydroxylapatite

    • Polylactic Acid (PLLA)

  • Microdermabrasion Devices

  • Microneedling Devices

  • Others

• End Use (Revenue, USD Million, 2021 - 2033)

  • B2B

  • B2C